n-3 fatty acids and gene expression

被引:249
作者
Deckelbaum, Richard J.
Worgall, Tilla S.
Seo, Toru
机构
[1] Columbia Univ, Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA
[3] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
关键词
fatty acid; gene expression; EPA; eicosapentaenoic acid; DHA; docosahexaenoic acid; SREBP; sterolresponsive-element binding protein; PPAR; peroxisome proliferator-activated receptor;
D O I
10.1093/ajcn/83.6.1520S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Accumulating evidence in both humans and animal models clearly indicates that a group of very-long-chain polyunsaturated fatty acids, the n-3 fatty acids (or omega-3), have distinct and important bioactive properties compared with other groups of fatty acids. n-3 Fatty acids are known to reduce many risk factors associated with several diseases, such as cardiovascular diseases, diabetes, and cancer. The mechanisms whereby n-3 fatty acids affect gene expression are complex and involve multiple processes. As examples, n-3 fatty acids regulate 2 groups of transcription factors, such as sterol-regulatory-element binding proteins and peroxisome proliferator-activated receptors, that are critical for modulating the expression of genes controlling both systemic and tissue-specific lipid homeostasis. Modulation of specific genes by n-3 fatty acids and cross-talk between these genes are responsible for many effects of n-3 fatty acids.
引用
收藏
页码:1520S / 1525S
页数:6
相关论文
共 79 条
[1]   Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and insigs [J].
Adams, CM ;
Reitz, J ;
De Brabander, JK ;
Feramisco, JD ;
Li, L ;
Brown, MS ;
Goldstein, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52772-52780
[2]   Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents [J].
Ahuja, HS ;
Liu, S ;
Crombie, DL ;
Boehm, M ;
Leibowitz, MD ;
Heyman, RA ;
Depre, C ;
Nagy, L ;
Tontonoz, P ;
Davies, PJA .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :765-773
[3]   Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion [J].
Bagga, D ;
Wang, L ;
Farias-Eisner, R ;
Glaspy, JA ;
Reddy, ST .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1751-1756
[4]   Dietary ω-3, ω-6, and ω-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes -: A randomized volunteer study [J].
Baumann, KH ;
Hessel, F ;
Larass, I ;
Müller, T ;
Angerer, P ;
Kiefl, R ;
von Schacky, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (01) :59-66
[5]   Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the litigation of PPARγ [J].
Bell-Parikh, LC ;
Ide, T ;
Lawson, JA ;
McNamara, P ;
Reilly, M ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06) :945-955
[6]   Interleukin-8 production in human adipose tissue. Inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin [J].
Bruun, JM ;
Pedersen, SB ;
Richelsen, B .
HORMONE AND METABOLIC RESEARCH, 2000, 32 (11-12) :537-541
[7]   Peroxisome proliferator-activated receptor-γ upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells [J].
Burgermeister, E ;
Tencer, L ;
Liscovitch, M .
ONCOGENE, 2003, 22 (25) :3888-3900
[8]   Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements [J].
Cagen, LM ;
Deng, X ;
Wilcox, HG ;
Park, EA ;
Raghow, R ;
Elam, MB .
BIOCHEMICAL JOURNAL, 2005, 385 :207-216
[9]   DIETARY-FAT - EXOGENOUS DETERMINATION OF MEMBRANE-STRUCTURE AND CELL-FUNCTION [J].
CLANDININ, MT ;
CHEEMA, S ;
FIELD, CJ ;
GARG, ML ;
VENKATRAMAN, J ;
CLANDININ, TR .
FASEB JOURNAL, 1991, 5 (13) :2761-2769
[10]   Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration, in NIDDM patients [J].
Cominacini, L ;
Garbin, U ;
Fratta Pasini, A ;
Campagnola, M ;
Davoli, A ;
Foot, E ;
Sighieri, G ;
Sironi, AM ;
Lo Cascio, V ;
Ferrannini, E .
DIABETES, 1998, 47 (01) :130-133